Compare Cudis (CUDIS) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cudis vs Enzyme — how do they compare? Cudis trades at Rp19.13 (market cap Rp4,69M, Rp7,37M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 28.6× Cudis's market cap, and Cudis's supply is capped (247,5M / 1B CUDIS (25%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Cudis for 11 Days and Enzyme for 29 Days on average.
| CUDIS | MLN | |
|---|---|---|
Market Cap | Rp4,69M | Rp134,13M |
Volume (24h) | Rp7,37M | Rp104,56M |
Circulating Supply | 247,5M / 1B CUDIS (25%) | 3,3M MLN |
Typical Hold Time | 11 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cudis is trading at Rp19.346 with a market cap of Rp4.78M, showing bearish technical signals with 13 sell signals in moving averages. The token has limited circulation at 25% of max supply and short average hold time of 11 days. Current price sits near key support levels with RSI indicators suggesting potential oversold conditions. No recent protocol updates or ecosystem developments were identified.
Overall outlook remains cautious due to strong bearish technical signals and limited market depth. Key opportunity lies in potential oversold bounce from support levels, while major risks include low liquidity, high volatility, and the token's early adoption stage. Investors should monitor for increased trading volume and network activity.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cudis
CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.
Read more on CUDIS →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
